Lu AF82422 is really a mAb verified as Risk-free and nicely tolerated in a very phase I demo in healthier subjects and patients with PD (NCT03611569). A stage II study investigating the basic safety and efficacy in https://ksnr.org.in/multiple-system-atrophy/